KFDA banned sales of Rubini strain MMR vaccine

Published: 2002-05-31 06:56:00

Updated: 2002-05-31 06:56:00

The KFDA decided to suspend temporarily the sale of Rubini strain MMR vaccines until the time when the Central Pharmaceutical Affairs Council presents the data to prove its efficacy and other epidemiological survey results. The Central Pharmaceutical Affairs Council earlier took meetings twice af...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK